Company page

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc. is a public company traded under the ticker SYRS in the American market, with a market capitalization of approximately $5.37 billion. The company focuses on developing innovative therapies for cancer and genetic diseases. Syros aims to advance its pipeline of drug candidates through research and clinical trials.